First Bank & Trust’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Sell
1,607
-222
-12% -$67.9K 0.08% 162
2026
Q1
$458K Sell
1,829
-2,368
-56% -$589K 0.07% 161
2025
Q4
$1.15M Buy
4,197
+1,226
+41% +$335K 0.19% 92
2025
Q3
$779K Buy
2,971
+1,541
+108% +$375K 0.13% 115
2025
Q2
$313K Sell
1,430
-629
-31% -$134K 0.06% 181
2025
Q1
$461K Buy
2,059
+124
+6% +$34.2K 0.09% 142
2024
Q4
$634K Buy
1,935
+923
+91% +$290K 0.12% 117
2024
Q3
$304K Buy
+1,012
New +$310K 0.06% 183

Other funds holding WST

First Bank & Trust's WST Position: Q2 2026 in Review

First Bank & Trust reduced its West Pharmaceutical (WST) stake by 12% in Q2 2026, selling an estimated $67.9K and leaving 1,607 shares worth $577K. The position accounts for 0.08% of the portfolio, ranked #162.

First Bank & Trust first reported a position in WST in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q4 2025. 128 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • First Bank & Trust held 1,607 shares of West Pharmaceutical worth $577K as of Q2 2026.
  • First Bank & Trust sold 222 West Pharmaceutical shares in Q2 2026, an estimated $67.9K.
  • West Pharmaceutical made up 0.08% of First Bank & Trust's portfolio in Q2 2026, its #162 holding.
  • First Bank & Trust first reported a position in West Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • First Bank & Trust's West Pharmaceutical position peaked at $1.15M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.